Tumor-derived SCF binds to the c-Kit receptor on the MC surface (40), triggering degranulation to release VEGF/PDGF/FGF-2 (41), as well as activation of the β-catenin pathway and stimulation of protease expression to enhance the supportive effect on colon cancer cells. The gene discussed is FGF2; the disease is malignant colon neoplasm.